Today OXBT closed right on the short term declining tops line as I have it drawn. That increases the possibility of a gap in the morning. Problem is it's hard to tell in which direction it might gap but the fact that the price didn't decline enough on the last cycle to touch the rising bottoms line is bullish and makes me think gap up. Too bad I haven't been able to post a link to me charts. A picture is worth........
The day isn't over yet and with this stock you never know where it's going to close. There was some short covering near the open that caused a "pop" but the main reason I posted was I love your statement " If you want fast money-go somewhere else". OXBT gained almost 1000% in just 13 days. In the stock market that's about the fastest money I know of. If you know of a faster stock please share (lol). I do know what you're saying. A slow grind higher over the next couple of months is the thing bulls should be hoping for. Of course the term "slow grind" is a relative thing. For this stock a slow grind might average 3% a day.
You have the wrong view of short sellers. They are the people you should be polite to. You should offer them encouragement, cover them up as they sleep so they won't catch cold. They are important to your success as a bull. When a stock or an entire market for that matter has been beaten down as in the case of oxbt, short covering always provides the first surge of buying that turns the market & prices higher. After the rise is underway it is still repetitive waves of short covering that provides the pop. To many people here think the shorts are enemies driving down the price of the stock. That's just not true. If we had to rely only on the buying of those who are bullish, oxbt would still be under $2.50. It's the impulse, forced buying of the shorts as they repeatedly try to pick tops and fail that drives the price ever higher.
I never said it was a scam smith. What I said is, there is nothing better than shorting a scam. Smith I'm not kidding, I am bullish oxbt. If you had any idea how the markets work you would understand why you want a heavy short interest in oxbt at this time if you are bullish. But you don't understand it well enough at this point. Let me give you a small hint. The only way a trader can cover his short position is to buy the stock which is known as short covering. Short covering is the cause of more up gaps and skyrocket type rises than anything thing else. If you don't believe me Google it. The reason I'm telling you to sit on your hands is so you won't be tempted to sell by the things being said here and so you won't look foolish.
A.......no you're a liar michelle_michelle. If an attorney representing oxbt told you something like that it would be in violation of a dozen SEC rules not to mention a violation of client attorney privilege. It would have been more believable if you had claimed to be president of oxbt. So much any credibility you may have had.
Smith, I'm bullish on oxbt. If you're bullish you want the shorts. You want oxbt to have the largest short interest ever. I shouldn't have to explain this to you and I can't explain it now but I will after future events unfold. Until then try sitting on your hands.
You might want to read over the first posting under "headlines" . Terms and conditions are within the body of the 8-K.
•OXYGEN BIOTHERAPEUTICS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered SalEDGAR Online(Tue, Nov 19
At some point we will need the fuel they will provide. So rather than discourage them please do your best to encourage them in their efforts. Thanks for your help.
We need the shorts. Please don't discourage them.
OK I found it. I took it as meaning that OXBT had submitted the results of the tests the FDA had requested and are now waiting to hear back from the FDA. The tests addressed all questions the FDA had as I remember them, so unless the FDA now has something new that should be it. If there's nothing new then we are just waiting on their answer. The OK to resume phase IIb clinical studies in the US would be a very big deal. It would bring back many of the long term investors that bailed out when Oxycyte was first put on clinical hold a couple years ago. Since results from phase IIb trials done in Israel and Switzerland can also be submitted to the FDA in fulfillment of US trials, it could mean that we a are closer to making it past that FDA hurdle than most realize. Anything that puts Oxycyte back on track is very big and will send this stock much higher. In the mean time we may see Wundacyte pass trials before long. The FDA process for topical treatments is much shorter and easier than it is for IV drugs like Oxycyte. A product like Wundacyte has a huge market. In fact I believe it's potential is so large that product alone could attract a buy out.
Can you give me the date of that statement? I remember reading it but I can't find it now. At the time I remember thinking it had probably been made prior to but published after the Sept 23 announcement.
The $3 target made long before the merger. In fact I don't think there are really any analysts following oxbt except for the one guy they force to and he'd rather be doing something else. There's nothing in the chart that would suggest it's going back to a buck, so my question is, do you have anything that would support your statement or is this just guessing and wishing?
Actually the FDA has stated they will grant fast track approval for the drug levosimenden. This fast track would apply to any company wishing to submit levosimenden for approval. Since OXTB owns the North American rights we can assume only they will be applying. When the oxbt submits it's final protocol for the trials the FDA will either approve, reject it or ask that it be modified. Until the protocol is approved you won't see anything on the FDA site about it and the FDA officials won't say anything either.
Latest short interest reports 1,221,000 shares short compared to 271,000 previously. So the fuel is there to get the ball rolling. Hopefully prices just grind higher holding shorts in as long as possible.